This message serves as an update to CSMS # 56244578, focusing on the FDA’s transition plan for medical devices marketed under Emergency Use Authorization (EUA) or enforcement policy during the COVID-19 Pandemic, which was issued on May 12, 2023. Enforcement Policy Devices within List 1: Phase 3 of the “Transition Plan for Medical Devices Falling […]
FDA’s CSMS # 58306521 – Update on Transition Plan for Medical Devices Marketed Under EUA or Enforcement Policy Amid COVID-19 Pandemic

